ISoP 2025 - International Society of Pharmacovigilance Annual Meeting

Topics

• Media, communication and transparency
  
  • Communicating about risks to patients
  • Communicating about harm and benefit to professionals
  • Social networks and Good Communication Practice
  • Media and drug information
• Concepts and methods in pharmacovigilance
  
  • Signal detection in pharmacovigilance
  • ADR’s causality and frequency assessment
  • Regional pharmacovigilance centers
  • Risk-Management Plans
• Ecopharmacovigilance
• Studies in pharmacovigilance
  
  • Observational studies
  • Post authorization safety studies
  • Drug utilization studies
  • Clinical trials
• Globalization of drug manufacturing, drug use and drug safety
  
  • Antibiotics and multiresistant microbials
  • Counterfeit medicines and pharmacovigilance
• EU Pharmacovigilance legislation
• Pharmacovigilance in neglected parasitic and emerging infectious diseases
• Herbal Medicines and ethno-pharmacovigilance
• Pharmacovigilance in biologicals
• Pharmacogenetics in pharmacovigilance and personalized treatments
• Pharmacovigilance in special patients groups and settings
  
  • Pharmacovigilance in oncology
  • Pharmacovigilance in psychiatry
  • Pharmacovigilance in patients with orphan diseases receiving orphan drugs
  • Pharmacovigilance in HIV infected patients
  • Paediatric pharmacovigilance
  • Pharmacovigilance in hospitals
• Pharmacovigilance of women’s medicines and reproductive health
  
  • Women’s medicines
  • Pharmacovigilance in pregnancy
  • Drugs in in-vitro fertilisation
• Vaccines pharmacovigilance
• Medication errors and preventable ADRs
• Education and training in pharmacovigilance